"There is a clear and urgent need for this product."
- Ben Broom, Head of Pulse Clarity at Pulse
Rokstone believes this scheme goes beyond traditional critical illness & cancer cover, offering a comprehensive support package alongside a financial lumpsum payout for 95% of cancers.
The scheme offers a dedicated care plan which provides support & guidance through both the NHS and private cancer pathways, up to 16 hours of emotional & practical support delivered by dedicated cancer support staff, and pre-diagnosis support to encourage policyholders to make healthy lifestyle choices as well as provide awareness of symptoms that could need investigating.
Reframe Cancer’s personalised, patient-centric service across the cancer pathway will be delivered by cancer nurse specialists and designed to expedite diagnosis and aid treatment to deliver better outcomes.
Rokstone’s cancer scheme targets the younger working-age population who are often underinsured for critical illness. Since the early 1990s, cancer rates in people aged 25-49 have risen by more than a fifth (22%); Cancer Research UK estimates that 1 in 2 people will be diagnosed with cancer in their lifetime.
Aventum has successfully trialled the scheme with its own 500+ employees, proving its effectiveness. The scheme is now being launched nationwide.
“Accident & Health (A&H) has been a difficult market for brokers in recent years with a severe lack of capacity and limited underwriters who are true specialists. We give brokers that expertise, backed by a global data-led MGA with a sterling reputation. We’re proud and delighted to play our part in bringing this vital scheme to market,” explained Darren Delande, Head of A&H at Rokstone.
Ben Broom, Head of Pulse Clarity at Pulse, agreed: “Traditionally, people have tended to consider policies like Critical Illness (CI) and Life Insurance when they first take out a mortgage, but the rising average age of first-time buyer (FTB) homeownership in the UK means fewer people discuss these critical covers early, leaving them vulnerable, especially against the backdrop of lengthy NHS waiting lists and regional variations in cancer treatment.”
He believes there's a “clear and urgent need for this product […] We’re delighted to be partnering with them & Reframe Cancer to launch this scheme.”
“Over the past decade, we’ve built a reputation for developing best-in-class cancer navigation and support solutions for the insurance & employer sectors. Our latest collaboration with Pulse Insurance leverages this expertise to deliver a groundbreaking insurance solution, and we’re thrilled to partner with them on this ambitious journey,” concluded Mark Stephenson, CEO of Reframe Cancer.
